Canada markets close in 5 hours 23 minutes

Lobe Sciences Ltd. (LOBE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.01500.0000 (0.00%)
As of 03:59PM EDT. Market open.
Full screen
Previous Close0.0150
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's Range0.0150 - 0.0150
52 Week Range0.0100 - 0.0300
Volume0
Avg. Volume20,805
Market Cap2.471M
Beta (5Y Monthly)2.41
PE Ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings DateJul 30, 2024 - Aug 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Lobe Sciences Announces Update

    VANCOUVER, British Columbia, June 04, 2024--Company Exploring Alternative Value Creation Opportunities; $500,000 Convertible Note Issued; Balance Sheet Strengthened; AGM Set for 22 July 2024

  • Business Wire

    Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise

    VANCOUVER, British Columbia, June 03, 2024--Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Wesley Ramjeet has agreed to join its Board of Directors in the coming months. With over two decades of experience as a mission-focused leader, Ramjeet is recognized for his exceptional ability to navigate complex transactions including acquisitions, initial publi

  • Business Wire

    Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors

    VANCOUVER, British Columbia, May 31, 2024--Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced that Frederick D. Sancilio Ph.D. has agreed to join its Board of Directors. Dr. Sancilio brings over four decades of successful experience in pharmaceutical sciences and biopharmaceutical research, further strengthening Lobe Sciences' commitment to pioneering advancemen